The early Phase 2 clinical study of JTS-653 in Post-Herpetic Neuralgia
Phase 2
- Conditions
- Post-Herpetic Neuralgia
- Registration Number
- JPRN-jRCT2080221142
- Lead Sponsor
- JAPAN TABACCO INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
The patient who passed for 3 months or more after the herpes zoster onset.
Exclusion Criteria
The patient who has other chronic pains in the PHN affected part
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method